This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Martine Michaud: Innovator in Neuroprotective Pharmaceutical Compositions
Introduction
Martine Michaud is a notable inventor based in Montpellier, France. She has made significant contributions to the field of neuroprotection through her innovative pharmaceutical compositions. Her work focuses on developing treatments for serious neurological conditions, showcasing her dedication to advancing medical science.
Latest Patents
Martine Michaud holds a patent for a neuroprotective pharmaceutical composition that contains stereoisomers of specific compounds. The invention relates to pharmaceutical compositions for neuroprotection, specifically utilizing the compound (1S,2R) 1-[1-(2-thienyl)-2-alkylcyclohexyl]piperidine or (1S,2R) 1-[1-(2-furanyl)-2-alkylcyclohexyl]piperidine, along with their pharmaceutically acceptable salts. The synthesis and method of separation of racemic mixtures to provide pure enantiomers are also presented. These compositions are intended for the treatment of stroke, CNS trauma, and Alzheimer's disease. Martine Michaud has 1 patent to her name.
Career Highlights
Martine Michaud is affiliated with the Centre National de la Recherche Scientifique, where she conducts her research and development. Her work has been instrumental in advancing the understanding of neuroprotective agents and their applications in treating neurological disorders.
Collaborations
Martine has collaborated with notable colleagues, including Jean-Marc Kamenka and Marie-Jeanne Drian, who have contributed to her research endeavors. Their combined expertise has enhanced the quality and impact of her work in the field.
Conclusion
Martine Michaud's contributions to neuroprotective pharmaceutical compositions highlight her innovative spirit and commitment to improving healthcare. Her work continues to pave the way for advancements in the treatment of neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
